Referred Tests#AANAM 2017 Live Blog
Share this:
Mayo Clinic neurologists, researchers, and a wide spectrum of allied health staff are in Boston for the 69th American Academy of Neurology Annual Meeting. Follow this blog for live updates from #AANAM as we attend the conference, mingle with colleagues at booth #685, and have a little fun. Have a comment or photo to share? Send it to us on Twitter @MayoClinicLabs or Facebook.
See you in Los Angeles for AAN 2018
We had an amazing time in Boston. Thank you for all of the great conversations, interactions, and teaching. We can't wait to see you in Los Angeles next year. The weather will be better for sure.
April 28 at 12:37 p.m.
Audio Insights: Eoin Flanagan, M.B., B.Ch.
Mayo Clinic Neurologist Eoin Flanagan, M.B., B.Ch., discusses his poster presentation from today's "MS and CNS Inflammatory Disease" session at AAN:
Area postrema syndrome more specific than extension of lesion on MRI for Neuromyelitis Optica Spectrum Disorder
April 27 at 3:45 p.m.
Audio Insights: MAP1B Antibody
Mayo Clinic Neurologist Andrew McKeon, discusses the AAN platform presentation "Microtubule Associated Protein (MAP) 1B: Antigen of PCA-2 IgG, Biomarker of Small-Cell Lung Carcinoma-related Paraneoplastic Neurological Autoimmunity" | View Abstract
April 27 at 1:45 p.m.
Audio Insights: Glycine Receptor Autoimmunity
Mayo Clinic Neurologist Andrew McKeon, discusses a poster presentation from today's "Neuromuscular and Clinical Neurophysiology (EMG)" session that he co-authored:
Case Control Analysis of Glycine Receptor Autoimmunity
April 26 at 4:05 p.m.
Day 4 Poster Sessions
Day 4 brings us another day of Mayo Clinic being well-represented in the AAN poster hall. Titles and links to the abstracts are provided below:
- Autonomic Testing Profiles in Scans without Evidence of Dopaminergic Deficit (SWEDD) | View Abstract
- Advanced 1H-MRS Detects Decreased Glutamate Levels in Amnestic MCI | View Abstract
- Association between Affective Symptoms and School Bullying Experiences in Adults with Autism Spectrum Disorders | View Abstract
- Clinical Characteristics of 32 Patients with Rapidly Progressive Dementia with Lewy Bodies | View Abstract
- FDG-PET, Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment | View Abstract
- Drug-Resistant Focal Epilepsy and Chronic Traumatic Encephalopathy: Clinical Evaluation and Pathological Findings | View Abstract
- Patient Experiences with Epilepsy Treatments: Thematic Review of the Qualitative Literature | View Abstract
- Can Admission Brain Natriuretic Peptide Level Predict Outcome after Intravenous Thrombolysis in Acute Ischemic Stroke? | View Abstract
April 26 at 12:29 p.m.
An Eye-Opening Daytime Sleepiness Study
As part of the AAN session on Highlights in Sleep Science, Mayo Clinic Neurologist Diego Carvalho, M.D., announced the results of an longitudinal Mayo Clinic study of aging. According to MedPage Today, "the study found that older individuals with normal cognition reporting excessive daytime sleepiness showed relatively greater increases in beta-amyloid plaque burdens in their brains. Among 283 study participants undergoing serial brain scans with the beta-amyloid tracer Pittsburgh Compound B, the fastest rates of amyloid accumulation were seen in those who indicated frequent daytime sleepiness."
April 25 at 2:45 p.m.
Audio Insights: Eoin Flanagan, M.B., B.Ch.
Mayo Clinic Neurologist Eoin Flanagan, M.B., B.Ch., discusses his presentation from today's "Neuromyelitis Optica and Other Autoimmune Disorders" session at AAN:
April 25 at 10:20 a.m.
Audio Insights: Day 2 Poster Sessions
As attendees mingled, munched, and sipped, another group of up-and-coming researchers and clinicians were discussing their latest abstracts. Of course, Mayo Clinic was very well-represented, and we were really excited to meet up with four of our colleagues to discuss their work:
Impulse Control Disorders Associated with Aripiprazole: Charlene Gaw
A Case of Post-EBV Cerebellitis Treated with IVIG: Ugur Sener, M.D.
Neurologic and Cranial Manifestations of Erdheim-Chester Disease: Natalie Parks, M.D.
Hyperglycemic Chorea/Hemiballism Ascertained at a Large Medical Center over 15 Years: Frequency & Characteristics: Conor Ryan, M.D.
April 24 at 10:15 p.m.
Audio Insights: Most Looking Forward to at AAN
Mayo Clinic Neurologist Christopher Klein, M.D., discussed what he is most looking forward to learning about at AAN.
April 24 at 2:24 p.m.
Audio Insights: Christopher Boes, M.D.
Mayo Clinic Neurologist Christopher Boes, M.D., F.A.A.N., received the Lawrence C. McHenry Award, an award for the history of neurology, sponsored by the American Academy of Neurology. We caught up with Dr. Boes on the floor of the exhibit hall to learn more about the fascinating history he uncovered and shared with the neurology world.
April 23 at 10:26 p.m.
Audio Insights: Day 1 Poster Sessions
Mayo Clinic Neurology physicians, scientists, fellows, and residents presented scores of posters and abstracts on Sunday. We were lucky enough to catch up with three of our colleagues during the poster session.
Powassan Virus Causing Post-Encephalitic Parkinsonism: Shivam Mittal, M.B.B.S.
Heart Rate Variability as a Screening Tool for Parkinson’s Disease Has Age-Dependent
Performance: Michael Christiansen, M.D.
Perioperative Management of Autoimmune Myasthenia Gravis in Patients Undergoing
Thymectomy: Francis Huttinger, M.D.
April 23 at 1:35 p.m.
Audio Insights: Importance of AAN
We caught up with Mayo Clinic Neurologist Christopher Klein, M.D., at this year's annual meeting. He shared with us his thoughts regarding how important conferences like AAN are to the profession.
April 23 at 11:31 a.m.
Excited for Day 1 at AAN
It is a picture-perfect day in Boston. The sun is finally out after a day of rain. The exhibit hall just opened. Our team can't wait to start talking to each of you about your practice, challenges, and opportunities to collaborate.
